Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP756793.RASadAT-5WIps2M-1B3PHlt-yEL1JWS10DZRgSBGOGCDs130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756793.RASadAT-5WIps2M-1B3PHlt-yEL1JWS10DZRgSBGOGCDs130_provenance.
• NP756799.RAT2b9D8yKSX09fAA4G5U1-_zZG1gUf_MqDZEa79pb_vI130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756799.RAT2b9D8yKSX09fAA4G5U1-_zZG1gUf_MqDZEa79pb_vI130_provenance.
• assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP736704.RACQORGDbUd7ciFk8vk5GZcSZYWBztsFqeVPREx-aopbM130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736704.RACQORGDbUd7ciFk8vk5GZcSZYWBztsFqeVPREx-aopbM130_provenance.
• NP1353691.RATt3DgML-qgvYBQEN14k6wqDq0ytSUwez6P6vV2EvA7U130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353691.RATt3DgML-qgvYBQEN14k6wqDq0ytSUwez6P6vV2EvA7U130_provenance.
• NP1353687.RAqeE-Jt8Pf47-AxGOLIOMdiXSuoEcr_OwhOPbhjiMiXQ130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353687.RAqeE-Jt8Pf47-AxGOLIOMdiXSuoEcr_OwhOPbhjiMiXQ130_provenance.
• NP1353689.RAu03Gdn3TOOGTAujt8v16s5WaP4bVcPjC8Kwo2Qq_eLA130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353689.RAu03Gdn3TOOGTAujt8v16s5WaP4bVcPjC8Kwo2Qq_eLA130_provenance.
• NP1353692.RAlQb4B8UYfjZQav9WxpMlqImfNjlUK5-ZbuoYiZdGrpg130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353692.RAlQb4B8UYfjZQav9WxpMlqImfNjlUK5-ZbuoYiZdGrpg130_provenance.
• NP756693.RALc3GDI2wtMSxWg5wEYzbW5gMvythOG-IgMClOGbybdw130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756693.RALc3GDI2wtMSxWg5wEYzbW5gMvythOG-IgMClOGbybdw130_provenance.
• NP736595.RALWK_HlaT4l3Tn2Mp5PpcOany7D_IBlzo1zhoLIq4M1M130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736595.RALWK_HlaT4l3Tn2Mp5PpcOany7D_IBlzo1zhoLIq4M1M130_provenance.
• NP736720.RA5Prl31Rk1j3wr4WsjGWPt2PTfFDWpNoRBQGuoIqppac130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736720.RA5Prl31Rk1j3wr4WsjGWPt2PTfFDWpNoRBQGuoIqppac130_provenance.
• NP1353688.RAHxmO86NGPAneDRMpS5Ljueru0aYTonv87o9DHcsDKng130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353688.RAHxmO86NGPAneDRMpS5Ljueru0aYTonv87o9DHcsDKng130_provenance.
• NP1353690.RA6VR1MHW_4eOpQTDUu_tEKgP5DZldL6RP62EqlwWEeCM130_assertion description "[At 30 days after therapy bone marrow and spleen of mice treated with AdCMV.TPO were populated with a large number of polyploid megakaryocytes, but there was no evidence of circulating megakaryocytes in the liver or lungs and no pathologic bone abnormalities such as osteosclerosis or myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353690.RA6VR1MHW_4eOpQTDUu_tEKgP5DZldL6RP62EqlwWEeCM130_provenance.